<img alt="" height="1" width="1" />
FDA clears Shire drug for rare hereditary disease
BusinessWeek
The Food and Drug Administration said Thursday it approved a drug from Shire PLC to treat a rare inherited disease that can cause dangerous swelling in the limbs, face and intestines. The drug Firazyr was approved to treat flare-ups of hereditary ...
Firazyr (icatibant Injection) Approved For Acute Attacks Of Hereditary ...Medical News Today
Shire Self-Injected Anti-Swelling Drug Wins U.S. ApprovalBloomberg
Firazyr Approved for Rare Swelling DiseaseU.S. News & World Report
Family Practice News Digital Network -Boston Globe -Wall Street Journal
all 68 news articles &raquo;


More...